Global Serotonin Syndrome Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 1768

Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death.
US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global serotonin syndrome diagnosis and treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.
In 2018, the global Serotonin Syndrome market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Serotonin Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Serotonin Syndrome development in United States, Europe and China.

The key players covered in this study
AstraZeneca Plc.
Eli Lilly and Company
Forest Laboratories Inc.
GlaxoSmithKline plc.
Johnson & Johnson
Merck & Co., Inc.
Pfizer, Inc.
Sanofi S.A.
Ciron Drugs & Pharmaceuticals Pvt. Ltd.

Market segment by Type, the product can be split into
Serotonin Antagonists
Supportive Care
Gastrointestinal Decontamination
Others

Market segment by Application, split into
Hospital Use
Clinic Use
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Serotonin Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Serotonin Syndrome development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Serotonin Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Serotonin Syndrome Market Size Growth Rate by Type (2014-2025)
1.4.2 Serotonin Antagonists
1.4.3 Supportive Care
1.4.4 Gastrointestinal Decontamination
1.4.5 Others
1.5 Market by Application
1.5.1 Global Serotonin Syndrome Market Share by Application (2014-2025)
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Serotonin Syndrome Market Size
2.2 Serotonin Syndrome Growth Trends by Regions
2.2.1 Serotonin Syndrome Market Size by Regions (2014-2025)
2.2.2 Serotonin Syndrome Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Serotonin Syndrome Market Size by Manufacturers
3.1.1 Global Serotonin Syndrome Revenue by Manufacturers (2014-2019)
3.1.2 Global Serotonin Syndrome Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Serotonin Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Serotonin Syndrome Key Players Head office and Area Served
3.3 Key Players Serotonin Syndrome Product/Solution/Service
3.4 Date of Enter into Serotonin Syndrome Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Serotonin Syndrome Market Size by Type (2014-2019)
4.2 Global Serotonin Syndrome Market Size by Application (2014-2019)

5 United States
5.1 United States Serotonin Syndrome Market Size (2014-2019)
5.2 Serotonin Syndrome Key Players in United States
5.3 United States Serotonin Syndrome Market Size by Type
5.4 United States Serotonin Syndrome Market Size by Application

6 Europe
6.1 Europe Serotonin Syndrome Market Size (2014-2019)
6.2 Serotonin Syndrome Key Players in Europe
6.3 Europe Serotonin Syndrome Market Size by Type
6.4 Europe Serotonin Syndrome Market Size by Application

7 China
7.1 China Serotonin Syndrome Market Size (2014-2019)
7.2 Serotonin Syndrome Key Players in China
7.3 China Serotonin Syndrome Market Size by Type
7.4 China Serotonin Syndrome Market Size by Application

8 Japan
8.1 Japan Serotonin Syndrome Market Size (2014-2019)
8.2 Serotonin Syndrome Key Players in Japan
8.3 Japan Serotonin Syndrome Market Size by Type
8.4 Japan Serotonin Syndrome Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Serotonin Syndrome Market Size (2014-2019)
9.2 Serotonin Syndrome Key Players in Southeast Asia
9.3 Southeast Asia Serotonin Syndrome Market Size by Type
9.4 Southeast Asia Serotonin Syndrome Market Size by Application

10 India
10.1 India Serotonin Syndrome Market Size (2014-2019)
10.2 Serotonin Syndrome Key Players in India
10.3 India Serotonin Syndrome Market Size by Type
10.4 India Serotonin Syndrome Market Size by Application

11 Central & South America
11.1 Central & South America Serotonin Syndrome Market Size (2014-2019)
11.2 Serotonin Syndrome Key Players in Central & South America
11.3 Central & South America Serotonin Syndrome Market Size by Type
11.4 Central & South America Serotonin Syndrome Market Size by Application

12 International Players Profiles
12.1 AstraZeneca Plc.
12.1.1 AstraZeneca Plc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Serotonin Syndrome Introduction
12.1.4 AstraZeneca Plc. Revenue in Serotonin Syndrome Business (2014-2019)
12.1.5 AstraZeneca Plc. Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Serotonin Syndrome Introduction
12.2.4 Eli Lilly and Company Revenue in Serotonin Syndrome Business (2014-2019)
12.2.5 Eli Lilly and Company Recent Development
12.3 Forest Laboratories Inc.
12.3.1 Forest Laboratories Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Serotonin Syndrome Introduction
12.3.4 Forest Laboratories Inc. Revenue in Serotonin Syndrome Business (2014-2019)
12.3.5 Forest Laboratories Inc. Recent Development
12.4 GlaxoSmithKline plc.
12.4.1 GlaxoSmithKline plc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Serotonin Syndrome Introduction
12.4.4 GlaxoSmithKline plc. Revenue in Serotonin Syndrome Business (2014-2019)
12.4.5 GlaxoSmithKline plc. Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Serotonin Syndrome Introduction
12.5.4 Johnson & Johnson Revenue in Serotonin Syndrome Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Merck & Co., Inc.
12.6.1 Merck & Co., Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Serotonin Syndrome Introduction
12.6.4 Merck & Co., Inc. Revenue in Serotonin Syndrome Business (2014-2019)
12.6.5 Merck & Co., Inc. Recent Development
12.7 Pfizer, Inc.
12.7.1 Pfizer, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Serotonin Syndrome Introduction
12.7.4 Pfizer, Inc. Revenue in Serotonin Syndrome Business (2014-2019)
12.7.5 Pfizer, Inc. Recent Development
12.8 Sanofi S.A.
12.8.1 Sanofi S.A. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Serotonin Syndrome Introduction
12.8.4 Sanofi S.A. Revenue in Serotonin Syndrome Business (2014-2019)
12.8.5 Sanofi S.A. Recent Development
12.9 Ciron Drugs & Pharmaceuticals Pvt. Ltd.
12.9.1 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Serotonin Syndrome Introduction
12.9.4 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Revenue in Serotonin Syndrome Business (2014-2019)
12.9.5 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details